Open AccessThe role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia
Author(s) -
Theodoros Karantanos,
Patric Teodorescu,
Brandy Perkins,
Ilias Christodoulou,
Christopher Esteb,
Ravi Varadhan,
Eric Helmenstine,
Trivikram Rajkhowa,
Bogdan C. Paun,
Challice L. Bonifant,
W. Brian Dalton,
Lukasz P. Gondek,
Alison R. Moliterno,
Mark J. Levis,
Gabriel Ghiaur,
Richard J. Jones
Publication year - 2022
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.abl8952
Subject(s) - chemokine receptor , cancer research , myeloid leukemia , biology , myeloid , myelodysplastic syndromes , gene knockdown , immunology , haematopoiesis , receptor , medicine , chemokine , bone marrow , microbiology and biotechnology , apoptosis , stem cell , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom